相关实验视频
Updated: Jul 1, 2025

06:21
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
108
乳病:发病,疾病管理和对草药治疗的新见解
Pooja Mittal1, Disha Arora2, Smriti Parashar3
1Chitkara College of Pharmacy, Chitkara University, Rajpura, India.
Narra J
|March 8, 2024
概括
病 (CD) 是一种由质引发的自身免疫性疾病. 新兴研究突出了潜在的草药治疗方法,这可能为控制CD症状和开发先进疗法提供新的途径.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乳病 (CD) 是一种由质不耐受引起的流行自身免疫性疾病,影响大约1%的人口.
- 遗传倾向,特别是人类白细胞抗原 (HLA) DQ2和HLA DQ8基因的存在,增加了对CD的敏感性.
- 目前的管理完全依赖于严格的无质饮食,需要探索替代疗法.
研究的目的:
- 提供关于乳病的发病和管理的最新审查.
- 总结目前对CD草药治疗的理解.
- 突出植物提取物在管理CD的潜在好处.
主要方法:
- 关于最近关于乳病病因的研究的文献综述.
- 分析研究的研究,调查草药和植物提取物用于CD管理.
- 综合关于草药的抗炎,免疫调节和肠道治疗特性的信息.
主要成果:
- 几种草药和植物提取物显示出有前途的抗炎,免疫调节和肠道治疗特性.
- 这些特性表明它在治疗乳病方面具有潜在的有效性.
- 草药治疗为CD管理,诊断和治疗开发提供了新的前景.
结论:
- 基于草药的治疗方法代表了未来的乳病管理的一个有希望的领域.
- 对植物提取物的进一步研究可能会导致新的治疗策略.
- 整合草药可以补充CD患者现有的无质饮食.
更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Chronic Pancreatitis II: Collaborative Care
88
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
88
Irritable Bowel Syndrome III: Medical and Nursing Management
204
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
204
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163

